Skip to main content

Data Requests to Use Johnson and Johnson Data

Requests listing last updated October 14, 2020

All Requests

The YODA Project posts proposals once data access has been granted or denied.

186 Results
YODA PROJECT Protocol Number2019-3980
Product(s) of Interest
REMICADE® (Infliximab)
No. Trials Provided1
YODA PROJECT Protocol Number2018-3121
Product(s) of Interest
REMICADE® (Infliximab), SIMPONI® (Golimumab)
No. Trials Provided6
Published
Principal InvestigatorSiddharth Singh
Divison of Gastroenterology, University of California San Diego
Reports & Publications
YODA PROJECT Protocol Number2017-2306
Product(s) of Interest
REMICADE® (Infliximab), SIMPONI® (Golimumab)
No. Trials Provided5
Published
Principal InvestigatorSiddharth Singh
Divison of Gastroenterology, University of California San Diego
Reports & Publications
YODA PROJECT Protocol Number2017-2031
Product(s) of Interest
REMICADE® (Infliximab)
No. Trials Provided3
YODA PROJECT Protocol Number2017-1966
Product(s) of Interest
RISPERDAL CONSTA® (Risperidone), INVEGA SUSTENNA® (Paliperidone palmitate), RISPERDAL® (Risperidone)
No. Trials Provided19
Published
Principal InvestigatorJose M Rubio
The Zucker Hillside Hospital, Northwell Health
Reports & Publications
YODA PROJECT Protocol Number2017-1856
Product(s) of Interest
REMICADE® (Infliximab), STELARA® (Ustekinumab), SIMPONI® (Golimumab)
No. Trials Provided17
Published
Principal InvestigatorAshwin Ananthakrishnan
Massachusetts General Hospital
Reports & Publications
YODA PROJECT Protocol Number2017-1746
Product(s) of Interest
RAZADYNE® (Galantamine), INVOKANA® (Canagliflozin), TOPAMAX® (Topiramate), SIMPONI® (Golimumab), STELARA® (Ustekinumab), REMICADE® (Infliximab), RISPERDAL® (Risperidone)
No. Trials Provided43
YODA PROJECT Protocol Number2017-1706
Product(s) of Interest
STELARA® (Ustekinumab)
No. Trials Provided2
YODA PROJECT Protocol Number2017-1701
Product(s) of Interest
INVEGA SUSTENNA® (Paliperidone palmitate), RISPERDAL® (Risperidone)
No. Trials Provided6
YODA PROJECT Protocol Number2017-1676
Product(s) of Interest
RISPERDAL® (Risperidone), INVEGA® (Paliperidone)
No. Trials Provided11
Published
Principal InvestigatorHiroyuki Uchida
Keio University School of Medicine, Department of Neuropsychiatry
Reports & Publications
YODA PROJECT Protocol Number2017-1451
Product(s) of Interest
SIMPONI® (Golimumab), REMICADE® (Infliximab)
No. Trials Provided4
YODA PROJECT Protocol Number2016-1176
Product(s) of Interest
STELARA® (Ustekinumab)
No. Trials Provided3
YODA PROJECT Protocol Number2016-1122
Product(s) of Interest
ZYTIGA® (Abiraterone acetate)
No. Trials Provided1
YODA PROJECT Protocol Number2016-1103
Product(s) of Interest
ZYTIGA® (Abiraterone acetate)
No. Trials Provided2
YODA PROJECT Protocol Number2016-1057
Product(s) of Interest
ZYTIGA® (Abiraterone acetate)
No. Trials Provided2
YODA PROJECT Protocol Number2016-0912
Product(s) of Interest
THERMOCOOL® SMARTTOUCH™ Catheter (Ablation Catheter)
No. Trials Provided1
YODA PROJECT Protocol Number2016-0903
Product(s) of Interest
REMICADE® (Infliximab)
No. Trials Provided4
YODA PROJECT Protocol Number2016-0897
Product(s) of Interest
STELARA® (Ustekinumab)
No. Trials Provided2
YODA PROJECT Protocol Number2016-0880
Product(s) of Interest
INVEGA® (Paliperidone), RISPERDAL® (Risperidone), RISPERDAL CONSTA® (Risperidone), INVEGA SUSTENNA® (Paliperidone palmitate)
No. Trials Provided49
Published
Principal InvestigatorStefan Leucht
Department of Psychiatry and Psychotherapy, Klinikum rechts der Isar, Technische Universität München
YODA PROJECT Protocol Number2016-0734
Product(s) of Interest
SIRTURO® (Bedaquiline/TMC207)
No. Trials Provided2
YODA PROJECT Protocol Number2016-0716
Product(s) of Interest
INVEGA®
No. Trials Provided1
YODA PROJECT Protocol Number2015-0678
Product(s) of Interest
INVEGA®
No. Trials Provided1
Published
Principal InvestigatorSharon-Lise Normand
Harvard Medical School
YODA PROJECT Protocol Number2015-0617
Product(s) of Interest
INVEGA®
No. Trials Provided1
Concluded
Principal InvestigatorKarestan Koenen
Harvard School of Public Health
Reports & Publications
YODA PROJECT Protocol Number2015-0612
Product(s) of Interest
REMICADE® (Infliximab), STELARA® (Ustekinumab), SIMPONI® (Golimumab)
No. Trials Provided16
YODA PROJECT Protocol Number2015-0514
Product(s) of Interest
LEVAQUIN® (Levofloxacin)
No. Trials Provided1
YODA PROJECT Protocol Number2014-0401
Product(s) of Interest
REMICADE® (Infliximab)
No. Trials Provided1
YODA PROJECT Protocol Number2014-0340
Product(s) of Interest
INVOKANA® (Canagliflozin)
No. Trials Provided9
YODA PROJECT Protocol Number2014-0334
Product(s) of Interest
REMICADE® (Infliximab)
No. Trials Provided4
YODA PROJECT Protocol Number2014-0291
Product(s) of Interest
SIMPONI® (Golimumab), REMICADE® (Infliximab)
No. Trials Provided3
Published
Principal InvestigatorMichael Ward
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Reports & Publications
YODA PROJECT Protocol Number2018-3061
Product(s) of Interest
REMICADE® (Infliximab)
No. Trials Provided3
Concluded
Principal InvestigatorSiddharth Singh
Divison of Gastroenterology, University of California San Diego
Reports & Publications
YODA PROJECT Protocol Number2018-2801
Product(s) of Interest
ZYTIGA® (Abiraterone acetate)
No. Trials Provided2
Concluded
Principal InvestigatorXianming Tan
University North Carolina at Chapel hill
Reports & Publications
YODA PROJECT Protocol Number2017-2651
Product(s) of Interest
ZYTIGA® (Abiraterone acetate)
No. Trials Provided2
YODA PROJECT Protocol Number2017-2511
Product(s) of Interest
INVOKANA® (Canagliflozin)
No. Trials Provided1
Concluded
Principal InvestigatorRaphaël Porcher
Université Paris Descartes
Reports & Publications
YODA PROJECT Protocol Number2016-1171
Product(s) of Interest
ZYTIGA® (Abiraterone acetate)
No. Trials Provided1
YODA PROJECT Protocol Number2016-1058
Product(s) of Interest
ZYTIGA® (Abiraterone acetate)
No. Trials Provided1
Concluded
Principal InvestigatorDaniel Moreira
University of Illinois at Chicago
Reports & Publications
YODA PROJECT Protocol Number2016-1046
Product(s) of Interest
REMICADE® (Infliximab)
No. Trials Provided1
YODA PROJECT Protocol Number2016-0995
Product(s) of Interest
SIMPONI® (Golimumab)
No. Trials Provided1
YODA PROJECT Protocol Number2016-0979
Product(s) of Interest
ZYTIGA® (Abiraterone acetate)
No. Trials Provided1
YODA PROJECT Protocol Number2016-0884
Product(s) of Interest
DOXIL® (Doxorubicin hydrochloride)
No. Trials Provided2
Concluded
Principal InvestigatorJose Miguel Fernandez
Universidad Pompeu Fabra
Reports & Publications
YODA PROJECT Protocol Number2016-0774
Product(s) of Interest
PROCRIT® (Epoetin alfa)
No. Trials Provided2
YODA PROJECT Protocol Number2016-0767
Product(s) of Interest
SIRTURO® (Bedaquiline/TMC207)
No. Trials Provided2
YODA PROJECT Protocol Number2016-0766
Product(s) of Interest
INVEGA SUSTENNA® (Paliperidone palmitate), RISPERDAL® (Risperidone), INVEGA® , INVEGA® (Paliperidone), RISPERDAL CONSTA® (Risperidone)
No. Trials Provided15
YODA PROJECT Protocol Number2016-0725
Product(s) of Interest
INVEGA® (Paliperidone), INVEGA SUSTENNA® (Paliperidone palmitate)
No. Trials Provided12
YODA PROJECT Protocol Number2016-0698
Product(s) of Interest
SIMPONI® (Golimumab), REMICADE® (Infliximab)
No. Trials Provided4
Concluded
Principal InvestigatorAndreas Goebel
University of Liverpool
Reports & Publications
YODA PROJECT Protocol Number2015-0691
Product(s) of Interest
REMICADE® (Infliximab), SIMPONI® (Golimumab)
No. Trials Provided21
Concluded
Principal InvestigatorSiddharth Singh
Divison of Gastroenterology, University of California San Diego
Reports & Publications
YODA PROJECT Protocol Number2015-0677
Product(s) of Interest
REMICADE® (Infliximab), SIMPONI® (Golimumab)
No. Trials Provided8
Concluded
Principal Investigatorshomron Ben-Horin
Sheba Medical Center & Sun YatSen 1st affiliated hospital
Reports & Publications
YODA PROJECT Protocol Number2015-0676
Product(s) of Interest
RISPERDAL CONSTA® (Risperidone), RISPERDAL® (Risperidone)
No. Trials Provided2
Concluded
Principal InvestigatorRobin Emsley
Department of Psychiatry, Faculty of Medicine and Health Sciences, University of Stellenbosch
Reports & Publications
YODA PROJECT Protocol Number2015-0649
Product(s) of Interest
INVEGA SUSTENNA® (Paliperidone palmitate), INVEGA® (Paliperidone), RISPERDAL® (Risperidone), RISPERDAL CONSTA® (Risperidone), REMICADE® (Infliximab), TOPAMAX® (Topiramate)
No. Trials Provided20
Concluded
Principal InvestigatorChunhua Weng
Columbia University
Reports & Publications
YODA PROJECT Protocol Number2015-0587
Product(s) of Interest
SIRTURO® (Bedaquiline/TMC207)
No. Trials Provided1
YODA PROJECT Protocol Number2015-0565
Product(s) of Interest
ZYTIGA® (Abiraterone acetate)
No. Trials Provided1
Concluded
Principal InvestigatorSrikala Sridhar
Princess Margaret Cancer Center
Reports & Publications
YODA PROJECT Protocol Number2015-0527
Product(s) of Interest
REMICADE® (Infliximab)
No. Trials Provided9
YODA PROJECT Protocol Number2015-0522
Product(s) of Interest
REMICADE® (Infliximab)
No. Trials Provided1
Concluded
Principal InvestigatorByron Vaughn
University of Minnesota
Reports & Publications
YODA PROJECT Protocol Number2015-0416
Product(s) of Interest
INVOKANA® (Canagliflozin)
No. Trials Provided9
YODA PROJECT Protocol Number2014-0317
Product(s) of Interest
RISPERDAL CONSTA® (Risperidone)
No. Trials Provided2
Concluded
Principal InvestigatorJohn Carlson
Michigan State University - School Psychology Doctoral Program
Reports & Publications
YODA PROJECT Protocol Number2020-4416
Product(s) of Interest
STELARA® (Ustekinumab)
No. Trials Provided3
YODA PROJECT Protocol Number2020-4415
Product(s) of Interest
TRACLEER® (Bosentan), OPSUMIT® (Macitentan), UPTRAVI® (Selexipag)
No. Trials Provided13
Approved with DUA Signature
Principal InvestigatorSheila McCartan
Exploristics
YODA PROJECT Protocol Number2020-4413
Product(s) of Interest
INVOKANA® (Canagliflozin)
No. Trials Provided2
Ongoing
Principal InvestigatorAmbarish Pandey
University of Texas Southwestern Medical Center
YODA PROJECT Protocol Number2020-4410
Product(s) of Interest
ZYTIGA® (Abiraterone acetate)
No. Trials Provided6
Approved Pending DUA Signature
Principal InvestigatorAhmad Abuhelwa
Flinders University
YODA PROJECT Protocol Number2020-4409
Product(s) of Interest
INVOKANA® (Canagliflozin)
No. Trials Provided2
Ongoing
Principal InvestigatorFahim Ebrahimi
Clarunis - University Center for Gastrointestinal and Liver Diseases
YODA PROJECT Protocol Number2020-4390
Product(s) of Interest
RISPERDAL CONSTA® (Risperidone), RAZADYNE® (Galantamine)
No. Trials Provided2
Approved Pending DUA Signature
Principal InvestigatorMohamed Aziz Mezlini
Massachusetts General hospital. Harvard medical school
YODA PROJECT Protocol Number2020-4386
Product(s) of Interest
IMBRUVICA® (Ibrutinib)
No. Trials Provided2
YODA PROJECT Protocol Number2020-4363
Product(s) of Interest
STELARA® (Ustekinumab)
No. Trials Provided3
YODA PROJECT Protocol Number2020-4362
Product(s) of Interest
STELARA® (Ustekinumab), REMICADE® (Infliximab)
No. Trials Provided4
YODA PROJECT Protocol Number2020-4341
Product(s) of Interest
REMICADE® (Infliximab), SIMPONI® (Golimumab)
No. Trials Provided25
YODA PROJECT Protocol Number2020-4324
Product(s) of Interest
RAZADYNE® (Galantamine)
No. Trials Provided3
Approved Pending DUA Signature
Principal InvestigatorIris Sommer
University Medical Center Groningen
YODA PROJECT Protocol Number2020-4323
Product(s) of Interest
, RAZADYNE® (Galantamine)
No. Trials Provided8
Approved Pending DUA Signature
Principal InvestigatorPaul Schulz
University of Texas Health Science Center Houston
YODA PROJECT Protocol Number2020-4319
Product(s) of Interest
INVOKANA® (Canagliflozin)
No. Trials Provided6
Withdrawn/Closed
Principal InvestigatorKenichiro Sato
University of Tokyo
Reports & Publications
*Request originally approved but subsequently withdrawn
YODA PROJECT Protocol Number2020-4318
Product(s) of Interest
REMICADE® (Infliximab), SIMPONI® (Golimumab)
No. Trials Provided6
In progress
Principal InvestigatorVivek Rudrapatna
University of California, San Francisco
YODA PROJECT Protocol Number2020-4317
Product(s) of Interest
PROCRIT® (Epoetin alfa)
No. Trials Provided1
Approved Pending DUA Signature
Principal InvestigatorLei Zhang
Bristol Medical School, University of Bristol
YODA PROJECT Protocol Number2020-4311
Product(s) of Interest
ZYTIGA® (Abiraterone acetate)
No. Trials Provided1
YODA PROJECT Protocol Number2020-4310
Product(s) of Interest
INVOKANA® (Canagliflozin)
No. Trials Provided2
YODA PROJECT Protocol Number2020-4305
Product(s) of Interest
RISPERDAL® (Risperidone)
No. Trials Provided2
YODA PROJECT Protocol Number2020-4299
Product(s) of Interest
DARZALEX® (Daratumumab)
No. Trials Provided3
YODA PROJECT Protocol Number2020-4298
Product(s) of Interest
ZYTIGA® (Abiraterone acetate)
No. Trials Provided1
Ongoing
Principal InvestigatorDavid Lorente
Medical Oncology Service, Hospital Provincial de Castellón
YODA PROJECT Protocol Number2020-4276
Product(s) of Interest
TOPAMAX® (Topiramate)
No. Trials Provided38
Approved with DUA Signature
Principal InvestigatorThomas Riemer
Charité-Universitätsmedizin Berlin, corporate partner of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Institute of Clinical Pharmacology and Toxicology, Campus Charité Mitte, Charité Universitätsmedizin Berlin
YODA PROJECT Protocol Number2020-4275
Product(s) of Interest
RAZADYNE® (Galantamine),
No. Trials Provided3
YODA PROJECT Protocol Number2020-4244
Product(s) of Interest
INVOKANA® (Canagliflozin)
No. Trials Provided2
YODA PROJECT Protocol Number2020-4243
Product(s) of Interest
OLYSIO® (Simeprevir)
No. Trials Provided5
Withdrawn/Closed
Principal InvestigatorMami Seki
Shimane University School of Medicine, Department of Medical Informatics
Reports & Publications
Request originally approved but subsequently withdrawn: the Data Partner has terminated their license for the requested product
YODA PROJECT Protocol Number2020-4236
Product(s) of Interest
IMBRUVICA® (Ibrutinib)
No. Trials Provided1
YODA PROJECT Protocol Number2020-4234
Product(s) of Interest
REMICADE® (Infliximab)
No. Trials Provided1
YODA PROJECT Protocol Number2020-4231
Product(s) of Interest
TRACLEER® (Bosentan)
No. Trials Provided1
Approved with DUA Signature
Principal InvestigatorGisli Jenkins
University of Nottingham
YODA PROJECT Protocol Number2020-4215
Product(s) of Interest
TRACLEER® (Bosentan), OPSUMIT® (Macitentan)
No. Trials Provided3
Approved with DUA Signature
Principal InvestigatorGisli Jenkins
University of Nottingham
YODA PROJECT Protocol Number2020-4213
Product(s) of Interest
INVOKANA® (Canagliflozin)
No. Trials Provided2
YODA PROJECT Protocol Number2020-4211
Product(s) of Interest
INVOKANA® (Canagliflozin)
No. Trials Provided6
YODA PROJECT Protocol Number2020-4189
Product(s) of Interest
ZYTIGA® (Abiraterone acetate)
No. Trials Provided17
YODA PROJECT Protocol Number2020-4175
Product(s) of Interest
INVEGA® (Paliperidone), INVEGA SUSTENNA® (Paliperidone palmitate), RISPERDAL® (Risperidone)
No. Trials Provided7
YODA PROJECT Protocol Number2020-4165
Product(s) of Interest
INVOKANA® (Canagliflozin)
No. Trials Provided1
Ongoing
Principal InvestigatorZaid Hattab
National University Of Ireland Galway
YODA PROJECT Protocol Number2019-4146
Product(s) of Interest
ZYTIGA® (Abiraterone acetate)
No. Trials Provided1
Approved Pending DUA Signature
Principal InvestigatorGerhardt Attard
UCL
YODA PROJECT Protocol Number2019-4134
Product(s) of Interest
ZYTIGA® (Abiraterone acetate)
No. Trials Provided1
YODA PROJECT Protocol Number2019-4133
Product(s) of Interest
STELARA® (Ustekinumab)
No. Trials Provided1
Withdrawn/Closed
Principal InvestigatorJunko Takeshita
University of Pennsylvania
Reports & Publications
*Request originally approved but subsequently withdrawn: data from other sources not received
YODA PROJECT Protocol Number2019-4132
Product(s) of Interest
SIMPONI® (Golimumab)
No. Trials Provided1
Withdrawn/Closed
Principal InvestigatorMaureen Dubreuil
Boston University School of Medicine
Reports & Publications
*Request withdrawn prior to approval determination: Data Partner supports access through independent process
YODA PROJECT Protocol Number2019-4107
Product(s) of Interest
REMICADE® (Infliximab), SIMPONI® (Golimumab)
No. Trials Provided8
YODA PROJECT Protocol Number2019-4104
Product(s) of Interest
STELARA® (Ustekinumab)
No. Trials Provided3
YODA PROJECT Protocol Number2019-4105
Product(s) of Interest
STELARA® (Ustekinumab)
No. Trials Provided3
YODA PROJECT Protocol Number2019-4093
Product(s) of Interest
INVOKANA® (Canagliflozin)
No. Trials Provided2
YODA PROJECT Protocol Number2019-4092
Product(s) of Interest
SIMPONI® (Golimumab), REMICADE® (Infliximab)
No. Trials Provided11
Ongoing
Principal InvestigatorTianxi Cai
Department of Biostatistics, Harvard T.H. Chan School of Public Health
YODA PROJECT Protocol Number2019-4090
Product(s) of Interest
ZYTIGA® (Abiraterone acetate)
No. Trials Provided2
Ongoing
Principal Investigatorantoine THIERY-VUILLEMIN
Department of Medical Oncology, CHU Jean Minjoz, Franche-Comté, France
YODA PROJECT Protocol Number2019-4080
Product(s) of Interest
INVEGA® (Paliperidone), INVEGA SUSTENNA® (Paliperidone palmitate), RISPERDAL® (Risperidone), RISPERDAL CONSTA® (Risperidone)
No. Trials Provided23
YODA PROJECT Protocol Number2019-4078
Product(s) of Interest
INVEGA SUSTENNA® (Paliperidone palmitate)
No. Trials Provided3
YODA PROJECT Protocol Number2019-4077
Product(s) of Interest
INVOKANA® (Canagliflozin)
No. Trials Provided9
YODA PROJECT Protocol Number2019-4075
Product(s) of Interest
UPTRAVI® (Selexipag), TRACLEER® (Bosentan), OPSUMIT® (Macitentan)
No. Trials Provided5
Approved with DUA Signature
Principal InvestigatorRaymond Benza
The Ohio State University
YODA PROJECT Protocol Number2019-4071
Product(s) of Interest
INVOKANA® (Canagliflozin)
No. Trials Provided15
YODA PROJECT Protocol Number2019-4067
Product(s) of Interest
REMICADE® (Infliximab), SIMPONI® (Golimumab), STELARA® (Ustekinumab)
No. Trials Provided45
Ongoing
Principal InvestigatorFlorence Bourgeois
Harvard Medical School
YODA PROJECT Protocol Number2019-4066
Product(s) of Interest
SIMPONI® (Golimumab)
No. Trials Provided1
YODA PROJECT Protocol Number2019-4035
Product(s) of Interest
INVOKANA® (Canagliflozin)
No. Trials Provided2
YODA PROJECT Protocol Number2019-4026
Product(s) of Interest
STELARA® (Ustekinumab)
No. Trials Provided3
YODA PROJECT Protocol Number2019-4023
Product(s) of Interest
INVOKANA® (Canagliflozin)
No. Trials Provided2
Withdrawn/Closed
Principal InvestigatorBenjamin Gandesbery
Barnes-Jewish Hospital
Reports & Publications
*Request originally approved but subsequently withdrawn: insufficient resources
YODA PROJECT Protocol Number2019-4015
Product(s) of Interest
PLIVENSIA (Sirukumab)
No. Trials Provided2
YODA PROJECT Protocol Number2019-4013
Product(s) of Interest
ZYTIGA® (Abiraterone acetate)
No. Trials Provided1
YODA PROJECT Protocol Number2019-4001
Product(s) of Interest
HEALOS® (HEALOS and Leopard Cage)
No. Trials Provided1
YODA PROJECT Protocol Number2019-3999
Product(s) of Interest
ZYTIGA® (Abiraterone acetate)
No. Trials Provided16
YODA PROJECT Protocol Number2019-3995
Product(s) of Interest
INVOKANA® (Canagliflozin)
No. Trials Provided12
YODA PROJECT Protocol Number2019-3990
Product(s) of Interest
ZYTIGA® (Abiraterone acetate)
No. Trials Provided1
YODA PROJECT Protocol Number2019-3978
Product(s) of Interest
RISPERDAL® (Risperidone), INVEGA SUSTENNA® (Paliperidone palmitate), INVEGA® (Paliperidone), RISPERDAL CONSTA® (Risperidone)
No. Trials Provided39
YODA PROJECT Protocol Number2019-3958
Product(s) of Interest
RISPERDAL® (Risperidone), RISPERDAL CONSTA® (Risperidone), CONCERTA® (Methylphenidate HCl), TOPAMAX® (Topiramate), INVEGA SUSTENNA® (Paliperidone palmitate), INVEGA® (Paliperidone), INVEGA®
No. Trials Provided108
YODA PROJECT Protocol Number2019-3943
Product(s) of Interest
REMICADE® (Infliximab)
No. Trials Provided1
YODA PROJECT Protocol Number2019-3941
Product(s) of Interest
INVEGA SUSTENNA® (Paliperidone palmitate), RISPERDAL® (Risperidone), INVEGA® (Paliperidone)
No. Trials Provided23
Ongoing
Principal InvestigatorSøren Dinesen Østergaard
Aarhus University
YODA PROJECT Protocol Number2019-3938
Product(s) of Interest
CONCERTA® (Methylphenidate HCl), RISPERDAL® (Risperidone)
No. Trials Provided2
YODA PROJECT Protocol Number2019-3936
Product(s) of Interest
DARZALEX® (Daratumumab), INVEGA SUSTENNA® (Paliperidone palmitate), ZYTIGA® (Abiraterone acetate), RAZADYNE® (Galantamine)
No. Trials Provided6
YODA PROJECT Protocol Number2019-3893
Product(s) of Interest
SIMPONI® (Golimumab), REMICADE® (Infliximab)
No. Trials Provided6
YODA PROJECT Protocol Number2019-3886
Product(s) of Interest
ZYTIGA® (Abiraterone acetate)
No. Trials Provided1
YODA PROJECT Protocol Number2019-3865
Product(s) of Interest
STELARA® (Ustekinumab)
No. Trials Provided6
Ongoing
Principal InvestigatorRobert Gniadecki
University of Alberta, Department of Medicine & Dentistry, Division of Dermatology
YODA PROJECT Protocol Number2019-3864
Product(s) of Interest
PROCRIT® (Epoetin alfa), PREZISTA® (Darunavir), EDURANT® (Rilpivirine)
No. Trials Provided6
Withdrawn/Closed
Principal InvestigatorKin Wah Fung
National Library of Medicine
Reports & Publications
*Request originally approved but subsequently withdrawn
YODA PROJECT Protocol Number2019-3850
Product(s) of Interest
INVOKANA® (Canagliflozin)
No. Trials Provided1
YODA PROJECT Protocol Number2019-3842
Product(s) of Interest
STELARA® (Ustekinumab)
No. Trials Provided3
Withdrawn/Closed
Principal InvestigatorAdam Cheifetz
Beth Israel Deaconess Medical Center
Reports & Publications
*Request originally approved but subsequently withdrawn: anticipated insufficient values
YODA PROJECT Protocol Number2019-3840
Product(s) of Interest
IMBRUVICA® (Ibrutinib)
No. Trials Provided3
Withdrawn/Closed
Principal InvestigatorMaya Koren-Michowitz
Shamir (Assaf Harofe Medical Center)
Reports & Publications
*Request withdrawn prior to approval determination: ECG scans not available due to patient privacy concerns
YODA PROJECT Protocol Number2019-3829
Product(s) of Interest
DOXIL® (Doxorubicin hydrochloride)
No. Trials Provided2
YODA PROJECT Protocol Number2019-3827
Product(s) of Interest
INVEGA® (Paliperidone), INVEGA SUSTENNA® (Paliperidone palmitate), RISPERDAL CONSTA® (Risperidone), RISPERDAL® (Risperidone), INVEGA®
No. Trials Provided67
Ongoing
Principal InvestigatorAndreas Heinz
Charité - Universitätsmedizin Berlin
YODA PROJECT Protocol Number2019-3821
Product(s) of Interest
INVEGA SUSTENNA® (Paliperidone palmitate), INVEGA® (Paliperidone), RISPERDAL® (Risperidone), INVEGA®
No. Trials Provided16
Ongoing
Principal InvestigatorRobert McCutcheon
King's College London
YODA PROJECT Protocol Number2018-3813
Product(s) of Interest
ZYTIGA® (Abiraterone acetate)
No. Trials Provided1
YODA PROJECT Protocol Number2018-3765
Product(s) of Interest
SIMPONI® (Golimumab)
No. Trials Provided16
YODA PROJECT Protocol Number2018-3745
Product(s) of Interest
ZYTIGA® (Abiraterone acetate)
No. Trials Provided2
Ongoing
Principal InvestigatorDavid Lorente
Medical Oncology Service, Hospital Provincial de Castellón
YODA PROJECT Protocol Number2018-3743
Product(s) of Interest
STELARA® (Ustekinumab), REMICADE® (Infliximab)
No. Trials Provided6
YODA PROJECT Protocol Number2018-3737
Product(s) of Interest
SIMPONI® (Golimumab), STELARA® (Ustekinumab), REMICADE® (Infliximab)
No. Trials Provided23
Ongoing
Principal InvestigatorShailja Shah
Vanderbilt University Medical Center
YODA PROJECT Protocol Number2018-3704
Product(s) of Interest
SIMPONI® (Golimumab), PLIVENSIA (Sirukumab)
No. Trials Provided2
YODA PROJECT Protocol Number2018-3556
Product(s) of Interest
SIMPONI® (Golimumab), REMICADE® (Infliximab), STELARA® (Ustekinumab)
No. Trials Provided22
YODA PROJECT Protocol Number2018-3476
Product(s) of Interest
STELARA® (Ustekinumab), REMICADE® (Infliximab)
No. Trials Provided10
Ongoing
Principal InvestigatorVivek Rudrapatna
University of California, San Francisco
YODA PROJECT Protocol Number2018-3321
Product(s) of Interest
DARZALEX® (Daratumumab)
No. Trials Provided5
YODA PROJECT Protocol Number2018-3236
Product(s) of Interest
REMICADE® (Infliximab)
No. Trials Provided1
YODA PROJECT Protocol Number2018-3156
Product(s) of Interest
SIRTURO® (Bedaquiline/TMC207)
No. Trials Provided2
YODA PROJECT Protocol Number2018-3131
Product(s) of Interest
REMICADE® (Infliximab), STELARA® (Ustekinumab)
No. Trials Provided7
Ongoing
Principal InvestigatorSiddharth Singh
Divison of Gastroenterology, University of California San Diego
YODA PROJECT Protocol Number2018-3126
Product(s) of Interest
REMICADE® (Infliximab), STELARA® (Ustekinumab)
No. Trials Provided7
Ongoing
Principal InvestigatorSiddharth Singh
Divison of Gastroenterology, University of California San Diego
YODA PROJECT Protocol Number2018-3051
Product(s) of Interest
RISPERDAL® (Risperidone)
No. Trials Provided1
YODA PROJECT Protocol Number2018-3011
Product(s) of Interest
ZYTIGA® (Abiraterone acetate)
No. Trials Provided2
Ongoing
Principal InvestigatorDavid Lorente
Medical Oncology Service, Hospital Provincial de Castellón
YODA PROJECT Protocol Number2018-2946
Product(s) of Interest
YONDELIS® (Trabectedin)
No. Trials Provided4
Withdrawn/Closed
Principal InvestigatorSujana Movva
Fox Chase Cancer Center
Reports & Publications
*Request originally approved but subsequently withdrawn
YODA PROJECT Protocol Number2018-2931
Product(s) of Interest
SIMPONI® (Golimumab), REMICADE® (Infliximab)
No. Trials Provided11
YODA PROJECT Protocol Number2018-2761
Product(s) of Interest
REMICADE® (Infliximab)
No. Trials Provided1
YODA PROJECT Protocol Number2018-2746
Product(s) of Interest
REMICADE® (Infliximab)
No. Trials Provided1
Withdrawn/Closed
Principal InvestigatorKT Park
Pediatric Gastroenterology, Hepatology, and Nutrition, Stanford University
Reports & Publications
*Request originally approved but subsequently withdrawn: insufficient resources
YODA PROJECT Protocol Number2018-2711
Product(s) of Interest
STELARA® (Ustekinumab)
No. Trials Provided1
Withdrawn/Closed
Principal InvestigatorIñaki F. Trocóniz
Navarra University
Reports & Publications
*Request withdrawn prior to approval determination: revisions to proposal requested, but never resubmitted; data could not be do
YODA PROJECT Protocol Number2018-2686
Product(s) of Interest
ZYTIGA® (Abiraterone acetate)
No. Trials Provided1
YODA PROJECT Protocol Number2017-2486
Product(s) of Interest
PROCRIT® (Epoetin alfa)
No. Trials Provided5
YODA PROJECT Protocol Number2017-2381
Product(s) of Interest
SIMPONI® (Golimumab), REMICADE® (Infliximab)
No. Trials Provided4
YODA PROJECT Protocol Number2017-2326
Product(s) of Interest
SIMPONI® (Golimumab)
No. Trials Provided1
Ongoing
Principal InvestigatorLiana Fraenkel
Yale University School of Medicine
YODA PROJECT Protocol Number2017-2036
Product(s) of Interest
ZYTIGA® (Abiraterone acetate)
No. Trials Provided2
Ongoing
Principal InvestigatorAntonio Fojo
Columbia University Medical Center/ James J. Peters VA Medical Center
YODA PROJECT Protocol Number2017-1846
Product(s) of Interest
INVEGA® (Paliperidone), RISPERDAL CONSTA® (Risperidone), INVEGA SUSTENNA® (Paliperidone palmitate), RISPERDAL® (Risperidone), INVEGA®
No. Trials Provided61
Ongoing
Principal InvestigatorAndreas Heinz
Department of Psychiatry und Psychotherapy, Charité-Universitätsmedizin Berlin
YODA PROJECT Protocol Number2017-1816
Product(s) of Interest
INVOKANA® (Canagliflozin)
No. Trials Provided6
YODA PROJECT Protocol Number2017-1671
Product(s) of Interest
RAZADYNE® (Galantamine), RAZADYNE® (Galantamine hydrobromide)
No. Trials Provided5
YODA PROJECT Protocol Number2017-1521
Product(s) of Interest
INVEGA® (Paliperidone), INVEGA SUSTENNA® (Paliperidone palmitate), RISPERDAL CONSTA® (Risperidone), RISPERDAL® (Risperidone)
No. Trials Provided9
YODA PROJECT Protocol Number2017-1466
Product(s) of Interest
INVOKANA® (Canagliflozin)
No. Trials Provided3
YODA PROJECT Protocol Number2017-1456
Product(s) of Interest
SIMPONI® (Golimumab), STELARA® (Ustekinumab)
No. Trials Provided3
YODA PROJECT Protocol Number2017-1356
Product(s) of Interest
ZYTIGA® (Abiraterone acetate)
No. Trials Provided2
YODA PROJECT Protocol Number2017-1276
Product(s) of Interest
REMICADE® (Infliximab)
No. Trials Provided1
YODA PROJECT Protocol Number2016-1196
Product(s) of Interest
REMICADE® (Infliximab)
No. Trials Provided1
YODA PROJECT Protocol Number2016-1136
Product(s) of Interest
ZYTIGA® (Abiraterone acetate)
No. Trials Provided2
YODA PROJECT Protocol Number2016-1107
Product(s) of Interest
REMICADE® (Infliximab)
No. Trials Provided7
Unknown - Revoked
Principal InvestigatorFrank Scott
University of Colorado Anschutz Medical Campus
Reports & Publications
Unknown; data access revoked, investigator has not reported results as requested.
YODA PROJECT Protocol Number2016-1038
Product(s) of Interest
TOPAMAX® (Topiramate)
No. Trials Provided2
YODA PROJECT Protocol Number2016-1026
Product(s) of Interest
INVOKANA® (Canagliflozin)
No. Trials Provided8
Withdrawn/Closed
Principal InvestigatorIssa Dahabreh
Brown University
Reports & Publications
*Request withdrawn prior to approval determination: revisions to proposal requested, but never resubmitted
YODA PROJECT Protocol Number2016-1005
Product(s) of Interest
INVEGA SUSTENNA® (Paliperidone palmitate), RISPERDAL CONSTA® (Risperidone), INVEGA® (Paliperidone), RISPERDAL® (Risperidone)
No. Trials Provided38
YODA PROJECT Protocol Number2016-0994
Product(s) of Interest
CONCERTA® (Methylphenidate HCl)
No. Trials Provided1
Withdrawn/Closed
Principal InvestigatorAlex Sturm
University of California, Los Angeles
Reports & Publications
*Request originally approved but subsequently withdrawn: insufficient resources
YODA PROJECT Protocol Number2016-0969
Product(s) of Interest
RISPERDAL® (Risperidone)
No. Trials Provided4
Unknown - Revoked
Principal InvestigatorSuzanne Reeves
University College London
Reports & Publications
Unknown; data access revoked, investigator has not reported results as requested.
YODA PROJECT Protocol Number2016-0960
Product(s) of Interest
PROCRIT® (Epoetin alfa)
No. Trials Provided8
Ongoing
Principal InvestigatorGary Rosner
Johns Hopkins University
YODA PROJECT Protocol Number2016-0919
Product(s) of Interest
REMICADE® (Infliximab), STELARA® (Ustekinumab)
No. Trials Provided12
YODA PROJECT Protocol Number2016-0765
Product(s) of Interest
RAZADYNE® (Galantamine)
No. Trials Provided12
YODA PROJECT Protocol Number2016-0738
Product(s) of Interest
OLYSIO® (Simeprevir)
No. Trials Provided1
Unknown - Revoked
Principal InvestigatorChristophe Moreno
CUB Hôpital Erasme
Reports & Publications
Unknown; data access revoked, investigator has not reported results as requested.
YODA PROJECT Protocol Number2015-0644
Product(s) of Interest
INVEGA SUSTENNA® (Paliperidone palmitate), TOPAMAX® (Topiramate), INVEGA® (Paliperidone), RISPERDAL® (Risperidone), RISPERDAL CONSTA® (Risperidone)
No. Trials Provided31
YODA PROJECT Protocol Number2015-0592
Product(s) of Interest
RISPERDAL® (Risperidone), INVEGA® (Paliperidone), RISPERDAL CONSTA® (Risperidone), RAZADYNE® (Galantamine), INVEGA SUSTENNA® (Paliperidone palmitate), CONCERTA® (Methylphenidate HCl)
No. Trials Provided38
Withdrawn/Closed
Principal InvestigatorYang Yan
Holmusk
Reports & Publications
*Request withdrawn prior to approval determination: revisions to proposal requested, but never resubmitted
YODA PROJECT Protocol Number2015-0560
Product(s) of Interest
STELARA® (Ustekinumab), SIMPONI® (Golimumab)
No. Trials Provided3
YODA PROJECT Protocol Number2015-0556
Product(s) of Interest
REMICADE® (Infliximab)
No. Trials Provided1
Withdrawn/Closed
Principal InvestigatorSigrid Nelson
Robarts Clinical Trials
Reports & Publications
*Request withdrawn prior to approval determination: endoscopy videos not available due to patient privacy concerns
YODA PROJECT Protocol Number2015-0539
Product(s) of Interest
CONCERTA® (Methylphenidate HCl)
No. Trials Provided1
Withdrawn/Closed
Principal InvestigatorAlex Sturm
University of California, Los Angeles
Reports & Publications
*Request originally approved but subsequently withdrawn: data could not be downloaded as requested
YODA PROJECT Protocol Number2015-0501
Product(s) of Interest
REMICADE® (Infliximab)
No. Trials Provided1
Withdrawn/Closed
Principal InvestigatorAnthony Otley
IWK Health Centre
Reports & Publications
*Request originally approved but subsequently withdrawn: data could not be downloaded as requested
YODA PROJECT Protocol Number2015-0500
Product(s) of Interest
ZYTIGA® (Abiraterone acetate)
No. Trials Provided1
YODA PROJECT Protocol Number2015-0406
Product(s) of Interest
ZYTIGA® (Abiraterone acetate)
No. Trials Provided1
Withdrawn/Closed
Principal InvestigatorNicola Schieda
The Ottawa Hospital - The University of Ottawa
Reports & Publications
*Request originally approved but subsequently withdrawn: CT scans not available due to patient privacy concerns
YODA PROJECT Protocol Number2014-0364
Product(s) of Interest
INVEGA SUSTENNA® (Paliperidone palmitate), INVEGA® (Paliperidone), RISPERDAL® (Risperidone), TOPAMAX® (Topiramate)
No. Trials Provided20
Ongoing
Principal InvestigatorStefan Leucht
Klinik für Psychiatrie und Psychotherapie der TU-München Klinikum rechts der Isar
YODA PROJECT Protocol Number2015-0339
Product(s) of Interest
STELARA® (Ustekinumab), REMICADE® (Infliximab), SIMPONI® (Golimumab), TREMFYA® (Guselkumab)
No. Trials Provided64
YODA PROJECT Protocol Number2014-0333
Product(s) of Interest
ZYTIGA® (Abiraterone acetate)
No. Trials Provided1
Unknown - Revoked
Principal InvestigatorGuru Sonpavde
University of Alabama, Birmingham (UAB) School of Medicine
Reports & Publications
Unknown; data access revoked, investigator has not reported results as requested.
YODA PROJECT Protocol Number2014-0287
Product(s) of Interest
REMICADE® (Infliximab)
No. Trials Provided2
Withdrawn/Closed
Principal InvestigatorWilliam J. Sandborn
University of California San Diego
Reports & Publications
*Request originally approved but subsequently withdrawn: data could not be downloaded as requested